Chapter 11 - Dr. Kessler
Dr. Adrian Kessler disappeared from Helixor two days after the birth.
Not physically missing.
Lawyered up.
Refused interviews.
Helixor publicly blamed an unauthorized embryology decision.
Convenient.
The clinic insisted no research procedure had been performed on Marianne during pregnancy beyond ordinary care.
Her medical records supported that.
The ethical violation was the embryo selection and lack of informed consent.
Still enormous.
But the baby was not poisoned.
Not engineered.
Not secretly medicated.
Marianne needed that distinction.
She would not allow adults to turn the child into a horror story.
Then the second variant was identified.
R-27.
Rare.
Associated with unusual resistance to the cellular pathway implicated in the old MTR cases.
Potentially protective.
Not harmful.
H-11 may actually have had a lower theoretical risk than H-14.
Claire began sobbing.
“We rejected the healthiest embryo?”
The geneticist corrected her.
“We cannot say that.”
Good.
No certainty where science did not provide it.
But Helixor believed the combination could reveal why some family members remained healthy.
Commercial value?
Potentially enormous.
Drug development.
Diagnostics.
Patents.
That explained Kessler.
Then why the birthmark?
Coincidence?
Mostly.
A familial physical trait linked through nearby inheritance patterns, perhaps.
Not diagnostic.
The mark was never the secret.
It was the trigger that made Evan think the wrong secret had surfaced.
Then Marianne learned H-11's biopsy sample had already been patented.
Not the embryo.
A discovery based on its cellular analysis.
Patent applicant:
Helixor.
Co-inventor:
Thomas Whitmore.
Evan’s dead father.
Impossible.
Thomas died nine years earlier.
Unless the underlying discovery was older.
Patricia confessed.
Thomas had identified the R-27 modifier decades ago.
In Elise Ward’s adopted daughter.
The baby from the 1987 photograph.
The first known person carrying both MTR-9 and R-27.
She had remained healthy.
Thomas concealed her identity to continue tracking her.
Then Helixor inherited his research.
They had been searching for the combination ever since.
Claire and Marianne’s family offered MTR-9.
Evan’s reproductive choices gave Helixor embryos to examine.
H-11 recreated the rare combination.
But where did R-27 come from?
Evan.
That meant his family carried it.
Marianne stared.
Thomas Whitmore hadn't merely studied the Ward family.
He possessed the same protective variant.
Why?
Patricia closed her eyes.
Because Thomas and the adopted Ward child were related.
“How?”
Patricia whispered:
“He was her father.”
Silence.
Thomas Whitmore had fathered a child with Elise Ward during the original research period.
A researcher and a nineteen-year-old participant.
The baby in Margaret’s arms.
The child later placed for adoption.
Thomas hid the paternity.
Then spent decades studying his own daughter’s genetics without acknowledging her.
Evan had a half-sister somewhere.
And H-11 had recreated the same genetic combination through Evan and Claire.
The baby was genetically similar to a woman Helixor had secretly tracked for thirty-eight years.
Then Marianne asked:
“Where is Evan’s half-sister?”
May you like
Patricia looked toward the door.
“You've already met her.”
